Status:
UNKNOWN
Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Embolic Stroke of Undetermined Source
Eligibility:
All Genders
18+ years
Brief Summary
Up to know, there is no clear diagnostic and therapeutic pathway for patients with embolic stroke of undetermined source (ESUS). This prospective registry study, which follows up adult ESUS patients f...
Detailed Description
The open-label, academic, prospective, monocentric, observational registry-study (Catch-up-ESUS registry study) started in 01/2018. All ESUS-patients (≥18 years) treated in our hospital are included a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Embolic stroke of undetermined source or cryptogenic stroke; defined as: non-lacunar brain infarction without proximal arterial stenosis or cardioembolic source or other etiology (e.g. vasculitis, cervical artery dissection)
- ≥18 years
- written consent to participation in the study register by the patient or the legal guardian or authorised representative at the time of inclusion in the study
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT03820375
Start Date
January 1 2018
End Date
January 1 2026
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig Maximilians University
Munich, Germany, 80539